Geneos Wealth Management Inc. - SPERO THERAPEUTICS INC ownership

SPERO THERAPEUTICS INC's ticker is SPRO and the CUSIP is 84833T103. A total of 86 filers reported holding SPERO THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.92 and the average weighting 0.3%.

Quarter-by-quarter ownership
Geneos Wealth Management Inc. ownership history of SPERO THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$9,000
-10.0%
5900.0%0.00%
Q3 2021$10,000
+11.1%
5900.0%0.00%
Q2 2021$9,000
-84.2%
590
-86.0%
0.00%
-100.0%
Q1 2021$57,000
-6.6%
4,2010.0%0.00%0.0%
Q4 2020$61,000
+79.4%
4,201
+16.3%
0.00%0.0%
Q3 2020$34,000
-27.7%
3,6110.0%0.00%
-33.3%
Q2 2020$47,000
+67.9%
3,6110.0%0.00%
+50.0%
Q1 2020$28,0003,6110.00%
Other shareholders
SPERO THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 3,932,209$76,246,00015.85%
Atlas Venture Associates XI, LLC 1,376,968$26,700,0004.23%
Atlas Venture Associates IX, LLC 1,376,968$26,700,0004.23%
BVF INC/IL 2,243,278$43,497,0001.71%
AWM Investment Company, Inc. 372,755$7,228,0000.92%
Alphabet Inc. 889,979$17,257,0000.83%
Rock Springs Capital Management LP 1,235,000$23,947,0000.51%
Novo Holdings A/S 576,702$11,182,0000.48%
Artal Group S.A. 500,000$9,695,0000.21%
Granahan Investment Management 420,320$8,150,0000.18%
View complete list of SPERO THERAPEUTICS INC shareholders